483
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.FDA 483 - Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Lianyungang Hongchuang Pharmaceutical Co. Ltd. in Lianyungang, China, an API manufacturer, revealed significant deficiencies. Observations included manufacturing equipment with corrosion and chipped surfaces, which is used for sterile injectable drug products. Additionally, the firm's Master Batch Records lacked complete instructions for critical production steps.
- Product Type
- Drugs
Open in Dashboard
ID · 98730089-453d-4cc3-909d-2967504ae1c4